Creatine kinase isoforms in ischemic heart disease.
The MM and MB isoenzymes of creatine kinase exist in serum as a collection of at least three major MM and two major MB isoforms. Each of these are derived from single tissue MM and MB isoforms, which are converted to these other forms by carboxypeptidase N after their release from necrotic skeletal and myocardial tissue. Measurement of the MM isoforms in ischemic heart disease is useful for early diagnosis of acute myocardial infarction and for the noninvasive determination of coronary artery reperfusion for infarction patients receiving thrombolytic therapy. Because MM is also released in acute skeletal-muscle disease, MB isoform measurements may have the highest clinical sensitivity. These determinations are important for providing objective information to cardiologists who need to make critical decisions concerning the management of these patients. I review the procedures for treating patients with myocardial infarction, the potential role of CK isoforms, and the methods currently available for isoform analysis, including high-resolution electrophoresis, isoelectric and chromatofocusing, and liquid chromatography. Rapid and highly sensitive methods are needed for implementation of CK-MM and MB isoforms for prospective emergency determinations for patients with acute myocardial infarction.
Wu
A H
AH
Department of Pathology and Laboratory Medicine, University of Texas Medical School, Houston 77025.
D000818:Animals; D002845:Chromatography; D002851:Chromatography, High Pressure Liquid; D003402:Creatine Kinase / Q000097:blood*; D004586:Electrophoresis; D005343:Fibrinolytic Agents / Q000627:therapeutic use; D006801:Humans; D007525:Isoelectric Focusing; D007527:Isoenzymes; D009203:Myocardial Infarction / Q000188:drug therapy / Q000201:enzymology*
D005343:Fibrinolytic Agents; D007527:Isoenzymes; D003402:Creatine Kinase